Filing Details

Accession Number:
0001209191-23-035590
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-06-08 20:54:06
Reporting Period:
2023-06-08
Accepted Time:
2023-06-08 20:54:06
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1761918 Erasca Inc. ERAS () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1283290 E Jonathan Lim C/O Erasca, Inc.
3115 Merryfield Row, Suite 300
San Diego CA 92121
Chairman & Ceo Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-06-08 100,000 $2.75 18,396,216 No 4 P Indirect By Jonathan E. Lim and Conyee T. Lim Family Trust, dated April 28, 2005
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Jonathan E. Lim and Conyee T. Lim Family Trust, dated April 28, 2005
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 11,899,360 Indirect By City Hill, LLC
Footnotes
  1. The securities reported herein may be deemed beneficially owned by each of (i) Jonathan E. Lim, M.D. and (ii) Conyee T. Lim, M.D., who are co-trustees of the Jonathan E. Lim and Conyee T. Lim Family Trust, dated April 28, 2005.
  2. Consists of shares held directly by City Hill, LLC ("City Hill"). Jonathan E. Lim, M.D. serves as the managing partner of City Hill. Dr. Lim exercises voting and dispositive control over the securities held by City Hill and is therefore deemed to be a beneficial owner of securities owned by City Hill. Dr. Limdisclaims beneficial ownership of the reported securities held by City Hill, except to the extent of his pecuniary interest therein.